Israel Englander Immunity Bio, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,243,706 shares of IBRX stock, worth $8.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,243,706
Previous 429,753
654.78%
Holding current value
$8.01 Million
Previous $1.29 Million
562.26%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IBRX
# of Institutions
274Shares Held
120MCall Options Held
2.47MPut Options Held
3.13M-
Vanguard Group Inc Valley Forge, PA21.8MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.2 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...